Recent Research Funding

Michael E. Duffey, PhD.

For decades, National Institutes of Health funding has supported Michael E. Duffey, PhD, whose work has been published in top journals such as Nature.

We receive funding from a variety of sources that recognize the value of our high-impact research.

  • Synaptic and Genetic Mechanisms of Sex-Specific Effects of Stress. Zhen Yan (Principal Investigator). NIH. $2,621,841. 4/1/2021-1/1/2026.
  • Renal considerations in the heat stress and hydration recommendations. Mark Parker (Co-Investigator). NIH National Institute for Occupational Safety and Health. 9/1/2019-8/1/2024.
  • Targeting Histone K4 Methylation for Treatment of Alzheimer's Disease and Related Dementia. Zhen Yan (Principal Investigator). NIH. $2,532,180. 8/1/2019-3/1/2024.
  • Investigating the Action and Physiological Role of Slc4a11 in the Cornea. Michael Duffey (Co-Investigator), Sangita Patel (Co-Investigator). NIH National Eye Institute. $1,972,804. 2/1/2018-1/1/2023.
  • Investigating the Action and Physiological Role of Slc4a11 in the Cornea (NIH R01 EY028580). Michael Duffey (Co-Investigator), Mark Parker (Principal Investigator), Sangita Patel (Co-Investigator). NIH. 1/1/2018-1/1/2023.
  • Investigating the Action and Physiological Role of Slc4a11 in the Cornea (NIH R01 EY028580). Michael Duffey (Co-Investigator), Mark Parker (Principal Investigator), Sangita Patel (Co-Investigator). NIH. 1/1/2018-1/1/2023.
  • Role of myosin IC in prostate cancer metastasis. Wilma Hofmann (Principal Investigator). NIH/NCI. $478,500. 8/1/2017-7/1/2022.
  • A Novel Epigenetic Mechanism for Alzheimer's Disease. Jian Feng (Co-Investigator), Zhen Yan (Principal Investigator). NIH. $1,993,750. 4/1/2017-3/1/2022.
  • A Novel Epigenetic Mechanism for Alzheimer's Disease. Jian Feng (Co-Investigator), Zhen Yan (Principal Investigator). NIH. $1,993,750. 4/1/2017-3/1/2022.
  • New Treatment Strategy for Alzheimer's Disease. Zhen Yan (Co-Principal Investigator). NIH. $438,625. 4/1/2020-3/1/2022.
  • Improving function after peripheral nerve injury. Susan Udin (Co-Investigator). SUNY Research Seed Grant Program. $22,500. 9/1/2020-2/1/2022.
  • Role of NANOG in improving function after peripheral nerve injury. Susan Udin (Co-Investigator). SUNY CTSI Translational Pilot Studies Program. $41,168. 1/1/2021-12/1/2021.
  • Physiological and Pathophysiological Basis of Stress. Zhen Yan (Principal Investigator). NIH. $1,993,750. 8/1/2015-7/1/2020.
  • Pathophysiology of Myocardial Remodeling in Heart Failure With Preserved Ejection Fraction. Brian Weil (Principal Investigator). American Heart Association. 7/1/2017-6/1/2020.
  • T3np in Cardiac Resuscitation – Pivotal Pre-Clinical Trial. Brian Weil (Principal Investigator). UB Center for Advanced Biomedical and Bioengineering Technology. 7/1/2018-6/1/2020.
  • Preclinical Evaluation of Systemic Cellular Postconditioning as a Novel Cardioprotective and Neuroprotective Therapy Following Cardiac Arrest. Brian Weil (Principal Investigator). The ZOLL Foundation. 12/1/2018-11/1/2019.
  • Novel Biomarkers of Extracellular Matrix Expansion and Interstitial Fibrosis in Heart Failure. Brian Weil (Principal Investigator). The Community Foundation for Greater Buffalo. 11/1/2018-10/1/2019.
  • Functions of D4 Dopamine Receptors in Prefrontal Cortex. Zhen Yan (Principal Investigator). NIH. $1,590,000. 7/1/2014-6/1/2019.
  • Novel Therapeutic Strategies for Autism. Zhen Yan (Principal Investigator). Nancy Lurie Marks Family Foundation. $540,000. 2/1/2016-1/1/2019.